These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2869683)

  • 21. [Hypersensitivity syndrome caused by allopurinol. A case of massive hepatic necrosis].
    González U; Reyes E; Kershenovich J; Orozco-Topete RL
    Rev Invest Clin; 1995; 47(5):409-13. PubMed ID: 8584813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug-induced lymphadenitis].
    Yin WH; Zhang HY; Li XF; Ma Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):192-4. PubMed ID: 20450768
    [No Abstract]   [Full Text] [Related]  

  • 23. [Case of ulcerative colitis associated with drug-induced hypersensitivity syndrome (DIHS) by salazosulfapyridine].
    Nishimura T; Obata H; Fujino H; Sonoda A; Sakamoto K; Mizuno C; Mizuno M; Shima T; Nakajyo S; Fujiyama Y
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jan; 104(1):36-41. PubMed ID: 17230004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood.
    Teague WG; Sutphen JL; Fechner RE
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):663-7. PubMed ID: 2863342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe acute hepatitis in the DRESS syndrome: Report of two cases.
    Lens S; Crespo G; Carrión JA; Miquel R; Navasa M
    Ann Hepatol; 2010; 9(2):198-201. PubMed ID: 20526017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events.
    Jobanputra P; Amarasena R; Maggs F; Homer D; Bowman S; Rankin E; Filer A; Raza K; Jubb R
    BMC Musculoskelet Disord; 2008 Apr; 9():48. PubMed ID: 18405372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis.
    Lennard TW; Farndon JR
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):96. PubMed ID: 6134567
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
    Leroux JL; Ghezail M; Chertok P; Blotman F
    Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
    [No Abstract]   [Full Text] [Related]  

  • 30. Azulfidine- (sulfasalazine-) induced hepatic injury.
    Kanner RS; Tedesco FJ; Kalser MH
    Am J Dig Dis; 1978 Oct; 23(10):956-8. PubMed ID: 31085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
    Schoonjans R; Mast A; Van den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
    Am J Gastroenterol; 1993 Oct; 88(10):1759-63. PubMed ID: 8105680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
    Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
    Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease.
    Boyer DL; Li BU; Fyda JN; Friedman RA
    J Pediatr Gastroenterol Nutr; 1989 May; 8(4):528-32. PubMed ID: 2566669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug hypersensitivity syndrome associated with a primary HHV6 infection].
    Debarbieux S; Deroo-Berger MC; Grande S; Najioullah F; Kanitakis J; Faure M; Claudy A
    Ann Dermatol Venereol; 2006 Feb; 133(2):145-7. PubMed ID: 16508598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
    Halmos B; Anastopoulos HT; Schnipper LE; Ballesteros E
    Ann Hematol; 2004 Apr; 83(4):242-6. PubMed ID: 13680174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA; van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypersensitivity reaction to sulfasalazine--another case.
    Jacobs E; Paulet P; Rahier J
    Gastroenterology; 1978 Dec; 75(6):1193. PubMed ID: 30678
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surface necroses of the skin following sulfasalazine therapy in ulcerative colitis].
    Krakamp B; Beinhoff U; Knöpfle G; Leidig P
    Med Klin (Munich); 1988 Sep; 83(18):611-2. PubMed ID: 2903432
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulphasalazine hepatotoxicity after 15 years' treatment.
    Holdsworth CD
    Br Med J (Clin Res Ed); 1983 Sep; 287(6394):759. PubMed ID: 6137258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.